Welcome to Bristol-Myers Squibb New Zealand
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb New Zealand aims to delivers on its commitments: to our patients and customers, to our employees, to our communities, and to our environment.

Bristol-Myers Squibb
Visit our global website to find out more about Bristol-Myers Squibb worldwide.
www.bms.com

News
9 June 2016: Opdivo (nivolumab) fully funded in New Zealand from 1 July 2016 for the treatment of advanced melanoma. 
2 May 2016:
Immuno-oncology agent Opdivo (nivolumab) approved in New Zealand for advanced melanoma and lung cancer.
 
Mission Our company’s mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Click here to read Bristol-Myers Squibb mission

Publications Find out more about Bristol-Myers Squibb worldwide.

Download or view our key corporate publications
Questions about our medicines?